Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Status:
COMPLETED
Trial end date:
2023-07-25
Target enrollment:
Participant gender:
Summary
A randomized remote, implementation trial in the Mass General Brigham network was performed on 200 patients with T2D at high CV or kidney risk. The study's primary objective was to create a remote diabetes management platform that improved the initiation and adherence to glucose-lowering medications with CV and kidney benefit and was evaluated by the primary outcome: increasing the proportion of patients with prescriptions for GDMT therapy by 6 months.